Last reviewed · How we verify
5-Hydroxytryptophan — Competitive Intelligence Brief
marketed
Serotonin precursor / amino acid supplement
Aromatic amino acid decarboxylase (enzyme substrate); indirect serotonin system modulation
Psychiatry / Neurology / Sleep Medicine
Small molecule
Live · refreshed every 30 min
Target snapshot
5-Hydroxytryptophan (5-Hydroxytryptophan) — Elizabeth Berry-Kravis. 5-Hydroxytryptophan (5-HTP) is a precursor to serotonin that increases central nervous system serotonin levels by crossing the blood-brain barrier and being converted to serotonin via aromatic amino acid decarboxylase.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 5-Hydroxytryptophan TARGET | 5-Hydroxytryptophan | Elizabeth Berry-Kravis | marketed | Serotonin precursor / amino acid supplement | Aromatic amino acid decarboxylase (enzyme substrate); indirect serotonin system modulation |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Serotonin precursor / amino acid supplement class)
- Clinical Academic Center (2CA-Braga) · 1 drug in this class
- Elizabeth Berry-Kravis · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 5-Hydroxytryptophan CI watch — RSS
- 5-Hydroxytryptophan CI watch — Atom
- 5-Hydroxytryptophan CI watch — JSON
- 5-Hydroxytryptophan alone — RSS
- Whole Serotonin precursor / amino acid supplement class — RSS
Cite this brief
Drug Landscape (2026). 5-Hydroxytryptophan — Competitive Intelligence Brief. https://druglandscape.com/ci/5-hydroxytryptophan. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab